Glutamine supplementation for young infants with severe gastrointestinal disease
Background: Endogenous glutamine biosynthesis may be insufficient to meet the needs of infants with severe gastrointestinal disease. Studies using animal models of gastrointestinal disease and controlled trials in adult patients have suggested that glutamine supplementation improves clinical outcomes. Objectives: To assess the evidence from randomised controlled trials that providing supplemental glutamine reduces mortality and morbidity in infants with severe gastrointestinal disease. Search...[Show more]
|Collections||ANU Research Publications|
|Source:||Cochrane Database of Systematic Reviews (CDSR)|
|01_Grover_Glutamine_supplementation_for_2007.pdf||85.7 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.